Today's picks

    A revival of hope..a new drug for breast cancer is a real progress for 20 years

    The US Food and Drug Administration (FDA) on Wednesday approved a new drug for one type of breast cancer, a development that one scientist says is the first real progress in 20 years.

    “This is the first time in more than 20 years that we are seeing advances in treatment,” lead researcher Stephen Johnston, MD, from the Royal Marsden Hospital NHS Foundation Trust, in London, said at a recent meeting of the European Society of Medical Oncology.

    Adjuvant for this type of breast cancer,” according to the “MedWeb” medical website. The drug called abemaciclib — the brand name Verzenio — is now approved for patients with early HR+, ER2 breast cancer, which makes up 70 percent of all breast cancers.

    October every year is Breast Cancer Awareness Month in all countries of the world. The month of October helps to increase interest in this disease and provide the necessary support to raise awareness of its seriousness and early detection and treatment, as well as providing patients with it with palliative care, according to the World Health Organization.